Free Trial

Varex Imaging Co. (NASDAQ:VREX) Stake Boosted by Assenagon Asset Management S.A.

Varex Imaging logo with Medical background

Assenagon Asset Management S.A. raised its position in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 37.3% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 185,506 shares of the company's stock after buying an additional 50,382 shares during the quarter. Assenagon Asset Management S.A. owned about 0.45% of Varex Imaging worth $2,211,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of VREX. Creative Planning boosted its position in shares of Varex Imaging by 9.2% during the 3rd quarter. Creative Planning now owns 19,644 shares of the company's stock worth $234,000 after purchasing an additional 1,654 shares in the last quarter. Innealta Capital LLC purchased a new stake in shares of Varex Imaging during the 2nd quarter worth $26,000. Isthmus Partners LLC boosted its position in shares of Varex Imaging by 1.2% during the 2nd quarter. Isthmus Partners LLC now owns 172,022 shares of the company's stock worth $2,534,000 after purchasing an additional 2,058 shares in the last quarter. First Eagle Investment Management LLC boosted its position in shares of Varex Imaging by 0.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 359,937 shares of the company's stock worth $5,302,000 after purchasing an additional 2,250 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Varex Imaging during the 2nd quarter worth $38,000.

Wall Street Analysts Forecast Growth

Separately, B. Riley started coverage on shares of Varex Imaging in a research report on Friday, August 23rd. They issued a "buy" rating and a $21.00 price objective on the stock.

View Our Latest Report on VREX

Insider Activity at Varex Imaging

In related news, CFO Shubham Maheshwari acquired 10,000 shares of the company's stock in a transaction dated Monday, August 12th. The stock was bought at an average price of $10.82 per share, with a total value of $108,200.00. Following the purchase, the chief financial officer now directly owns 56,063 shares in the company, valued at $606,601.66. The trade was a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Varex Imaging news, CFO Shubham Maheshwari bought 10,000 shares of the company's stock in a transaction that occurred on Monday, August 12th. The stock was purchased at an average price of $10.82 per share, with a total value of $108,200.00. Following the transaction, the chief financial officer now owns 56,063 shares in the company, valued at $606,601.66. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Kimberley E. Honeysett sold 2,578 shares of the company's stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $12.53, for a total value of $32,302.34. Following the completion of the transaction, the senior vice president now owns 275 shares of the company's stock, valued at approximately $3,445.75. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 5.20% of the stock is currently owned by corporate insiders.

Varex Imaging Price Performance

Shares of Varex Imaging stock traded up $0.07 on Friday, hitting $13.20. The company's stock had a trading volume of 487,120 shares, compared to its average volume of 480,990. Varex Imaging Co. has a 52-week low of $10.19 and a 52-week high of $21.50. The company has a quick ratio of 1.89, a current ratio of 3.34 and a debt-to-equity ratio of 0.67. The firm has a fifty day moving average price of $11.88 and a 200-day moving average price of $13.76. The company has a market capitalization of $539.88 million, a P/E ratio of 18.49 and a beta of 0.55.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its earnings results on Thursday, August 1st. The company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.05). Varex Imaging had a net margin of 4.11% and a return on equity of 6.11%. The firm had revenue of $209.00 million during the quarter, compared to analyst estimates of $209.50 million. During the same period in the previous year, the firm posted $0.37 EPS. The company's revenue for the quarter was down 10.0% compared to the same quarter last year. On average, equities research analysts expect that Varex Imaging Co. will post 0.46 earnings per share for the current fiscal year.

Varex Imaging Profile

(Free Report)

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

Further Reading

Institutional Ownership by Quarter for Varex Imaging (NASDAQ:VREX)

Should you invest $1,000 in Varex Imaging right now?

Before you consider Varex Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.

While Varex Imaging currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines